Gaponova A.; Nikonova A.; Deneka A.; Kopp M.; Kudinov A.; Skobeleva N.; Khazak V.; Ogawa L.; Cai K.; Duncan K.; Duncan J.; Egleston B.; Proia D.; Boumber Y.; Golemis E.
(2016)
©2016 AACR.Purpose: Small cell lung cancer (SCLC) is a highly aggressive disease representing 12% to 13% of total lung cancers, with median survival of <2 years. No targeted therapies have proven effective in SCLC. Although ...